What might a nurse expect to monitor closely in a patient receiving terbutaline?

In a patient receiving terbutaline, the primary focus is on monitoring the maternal heart rate and signs of tachycardia. Terbutaline is a beta-agonist that is often used to manage preterm labor by relaxing uterine muscles. However, one of the side effects of this medication is that it can also stimulate the cardiovascular system, leading to increased maternal heart rate (tachycardia). This can pose risks such as palpitations and potential cardiovascular strain, so it's critical for the nurse to observe the mother for any signs of tachycardia.

Additionally, it's important to monitor the impact of terbutaline on the mother’s overall cardiovascular status, as significant tachycardia could lead to adverse outcomes if not managed appropriately. Monitoring maternal heart rate allows for timely interventions if the heart rate becomes too elevated. This focus on maternal vital signs is essential for ensuring both maternal and fetal safety during treatment.

While monitoring fetal heart rate, fluid intake, or meconium presence are important in the broader context of labor management and fetal well-being, they are not the immediate priorities in the context of terbutaline administration. Thus, prioritizing maternal heart rate and tachycardia symptoms ensures that the primary concerns associated with the